Insights

High Growth NGS SeqWell operates in the genomics library preparation space with recent product launches like MosaiX and AgriPrep, indicating an expanding product portfolio and growing demand for high-throughput NGS workflows suitable for human, plant, and agricultural applications. This presents an opportunity to cross-sell to customers upgrading to high-performance kits and scaling sequencing projects.

Strategic Partnerships The company has pursued and maintained strategic partnerships with leading genomics institutions and has recently seen leadership changes in business development, signaling ongoing collaboration opportunities and potential for new co-development or distribution arrangements to broaden market reach.

Global Outreach With activity highlighted in multiple press releases and collaborations (e.g., PacBio partnership), SeqWell is positioning itself in a global landscape, suggesting potential for international sales efforts, channel partnerships, and support for translated documentation and regional regulatory considerations.

Diversified Applications MosaiX targets a wide range of high-throughput needs including whole-genome sequencing, plant and animal genomics, and targeted panels like WES, indicating sales opportunities across academic, clinical research, agricultural biotech, and translational research segments seeking scalable library prep solutions.

Financial Position With revenue in the mid-range bracket and a notable funding round, SeqWell presents a credible growth trajectory and budgetary capacity for partner-led initiatives, enabling targeted campaigns to security- and performance-focused buyers who value scalable, next-gen transposase technology.

seqWell Tech Stack

seqWell uses 8 technology products and services including Microsoft Advertising, iCIMS, WordPress, and more. Explore seqWell's tech stack below.

Media & News

seqWell's Email Address Formats

seqWell uses at least 1 format(s):
seqWell Email FormatsExamplePercentage
First.Last@seqwell.comJohn.Doe@seqwell.com
95%
Last@seqwell.comDoe@seqwell.com
5%

Frequently Asked Questions

What is seqWell's phone number?

Minus sign iconPlus sign icon
You can contact seqWell's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is seqWell's official website and social media links?

Minus sign iconPlus sign icon
seqWell's official website is seqwell.com and has social profiles on LinkedInCrunchbase.

How much revenue does seqWell generate?

Minus sign iconPlus sign icon
As of July 2026, seqWell's annual revenue is estimated to be $10M - $25M.

What is seqWell's SIC code NAICS code?

Minus sign iconPlus sign icon
seqWell's SIC code is 8731 - Commercial Physical and Biological Research NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does seqWell have currently?

Minus sign iconPlus sign icon
As of July 2026, seqWell has approximately 38 employees across 1 continents, including North America. Key team members include Chief Financial Officer: T. G.Vice President Of Research And Development: G. R.Senior Scientist: D. R.. Explore seqWell's employee directory with LeadIQ.

What industry does seqWell belong to?

Minus sign iconPlus sign icon
seqWell operates in the Biotechnology Research industry.

What technology does seqWell use?

Minus sign iconPlus sign icon
seqWell's tech stack includes Microsoft AdvertisingiCIMSWordPressShopifyWistiaWP EnginePiwikPiwik PRO Core.

What is seqWell's email format?

Minus sign iconPlus sign icon
seqWell's email format typically follows the pattern of First.Last@seqwell.com. Find more seqWell email formats with LeadIQ.

How much funding has seqWell raised to date?

Minus sign iconPlus sign icon
As of July 2026, seqWell has raised $25M in funding. The last funding round occurred on Feb 06, 2025 for $3.1M.

When was seqWell founded?

Minus sign iconPlus sign icon
seqWell was founded in 2014.
seqWell logo

seqWell

Biotechnology ResearchMassachusetts, United States11-50 Employees

seqWell develops scalable genomics technologies that streamline library preparation workflows for sequencing projects. Central to its approach is TnX, a transposase-based technology designed to increase the scalability and performance of tagmentation. Its library prep kits and fragmentation workflows support rapid scaling of both short- and long-read sequencing initiatives.

Headquartered in Beverly, Massachusetts, seqWell operates in the biotechnology research space, supplying genomic library construction and multiplexing workflow solutions to researchers and sequencing facilities. Its offerings address the needs of scientists undertaking high-throughput sequencing by simplifying library preparation and enabling scalable workflows across diverse applications. In February 2026, seqWell announced the launch of MosaiX, a library prep kit designed for high-throughput NGS applications, including human whole-genome sequencing, large plant and animal genomics, and targeted panels.

Section iconCompany Overview

Phone number
SIC Code
8731 - Commercial Physical and Biological Research
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2014
Employees
11-50

Section iconFunding & Financials

  • $25M

    seqWell has raised a total of $25M of funding over 6 rounds. Their latest funding round was raised on Feb 06, 2025 in the amount of $3.1Mas a series_unknown.

  • $10M - $25M

    seqWell's revenue is estimated to be in the range of $10M - $25M

Section iconFunding & Financials

  • $25M

    seqWell has raised a total of $25M of funding over 6 rounds. Their latest funding round was raised on Feb 06, 2025 in the amount of $3.1Mas a series_unknown.

  • $10M - $25M

    seqWell's revenue is estimated to be in the range of $10M - $25M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.